By IQT News posted 07 Aug 2019

(ScienceDaily) Researchers from Macquarie University and the University of New South Wales in Australia, have demonstrated a proof-of-concept device that uses bacterial DNA to identify the presence of Staphylococcus aureus positively in a patient sample — and to determine if it will respond to frontline antibiotics. The professors used a mobile phone and ultra-tiny semiconductor particles known as quantum dots.
Vinoth Kumar and colleagues subjected the DNA copies to a process known as lateral flow immunoassay — a paper-based diagnostic tool used to confirm the presence or absence of a target biomarker. The researchers use probes fitted with quantum dots to detect two unique genes, that confirms the presence of methicillin resistance in golden staph.
Methicillin-resistant S. aureus, or MRSA, is particular concern. It is estimates that 700,000 deaths globally could be attributed to antimicrobial resistance, such as methicillin-resistance. Rapid identification of MRSA is essential for effective treatment, but current methods make it a challenging process, even within well-equipped hospitals.

Subscribe to Our Email Newsletter

Stay up-to-date on all the latest news from the Quantum Technology industry and receive information and offers from third party vendors.

  • Forthcoming Events

    • IQT Fall | November 1-5, 2021
      Online & In-Person New York City
    • IQT, The Hague, The Netherlands | February 21-23, 2022
    • IQT Spring | May 10-12, 2022
      Online & In-Person San Diego
    • IQT Asia-Pacific Singapore 2022 | Dates Forthcoming
    • For additional information: info@3drholdings.com
0